We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Sunscreen Ingredient Enhances Cancer Treatment

By Biotechdaily staff writers
Posted on 23 Dec 2003
Studies have demonstrated that the cell-killing effects of radiation or standard chemotherapy drugs were enhanced when tumor cells were grown in dishes containing PABA (para-amino benzoic acid), an ingredient in some sunscreens. The results were presented at the International Conference on Molecular Targets and Cancer Therapies in Boston (MA, USA).

Researchers at New York University School of Medicine (NY, USA; www.med.nyu.edu) analyzed the effects of PABA and radiation alone and together on several cancer cell lines grown in laboratory dishes, as well as on implanted tumors in mice and chick embryos. In both experiments, they found that when PABA and radiation were combined, tumor growth was substantially reduced, compared to treatment with either PABA or radiation alone. In a similar fashion, the researchers found that PABA significantly improved the antitumor effects of drugs such as Taxol.

"These early findings suggest that PABA may optimize current cancer treatments by making tumor cells more vulnerable to certain chemotherapeutic drugs and radiation,” said Peter Brooks, Ph.D., associate professor of radiation oncology and cell biology at NYU, who made the presentation at the conference. "We will continue to access the cellular basis for PABA's effects.”




Related Links:
NYU School of Medicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
23 Dec 2003  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
23 Dec 2003  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
23 Dec 2003  |   BioResearch